Top Biotechnology companies in Germany by Total Liabilities

This ranking features the top 18 Biotechnology companies in Germany ranked by Total Liabilities, totaling a Total Liabilities of USD 141.37 B, for June 26, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Germany has the highest Total Liabilities ?

The Biotechnology company in Germany with the highest Total Liabilities is Bayer AG (XETRA: BAYN.DE) at USD 81.60 B.
Which Biotechnology company in Germany has the lowest Total Liabilities ?

The Biotechnology company in Germany with the lowest Total Liabilities is Vivoryon Therapeutics N.V. (Amsterdam Stock Exchange: VVY.AS) at None.

What are the top 10 Biotechnology companies in Germany by Total Liabilities ?

The top 10 Biotechnology companies in Germany by Total Liabilities are Bayer AG, Siemens Healthineers AG, MERCK Kommanditgesellschaft auf Aktien, BioNTech SE, Evotec SE, Biotest AG, Formycon AG, Eckert & Ziegler Strahlen- und Medizintechnik AG, Stratec SE and VITA 34 AG.
What are the bottom 10 Biotechnology companies in Germany by Total Liabilities ?

The bottom 10 Biotechnology companies in Germany by Total Liabilities are Vivoryon Therapeutics N.V., Anbio Biotechnology Class A Ordinary Shares, Mainz Biomed B.V., Heidelberg Pharma AG, Atai Life Sciences N.V., BRAIN Biotech AG, CureVac N.V., Immatics N.V., VITA 34 AG and Stratec SE.